tiprankstipranks
Trending News
More News >
RELIEF THERAPEUTICS Holding (RLFTF)
OTHER OTC:RLFTF

Compare RELIEF THERAPEUTICS Holding (RLFTF) vs. Competitors

Compare
306 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
RELIEF THERAPEUTICS Holding
$1.88
$81.46M
-1.50
-83.00%
Molecular Partners AG
CHF3.41
CHF145.75M
-2.05
1.40%
1 Buy
0 Hold
0 Sell
Moderate Buy
Basilea Pharmaceutica
CHF52.60
CHF634.73M
16.63
5.05%
1 Buy
0 Hold
0 Sell
Moderate Buy
Idorsia Ltd
CHF3.08
CHF791.95M
-8.17
178.99%
2 Buy
0 Hold
0 Sell
Moderate Buy
Newron Pharmaceuticals SpA
CHF14.60
$303.08M
-487.07
71.56%
1 Buy
0 Hold
0 Sell
Moderate Buy
Santhera Pharmaceuticals Holding
CHF14.12
$198.16M
-0.98
-3.81%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
RLFTF
RELIEF THERAPEUTICS Holding
0.51
-2.35
-82.17%
CH:MOLN
Molecular Partners AG
3.61
0.10
3.00%
CH:BSLN
Basilea Pharmaceutica
51.00
3.65
7.71%
CH:IDIA
Idorsia Ltd
3.08
2.01
188.66%
CH:NWRN
Newron Pharmaceuticals SpA
14.60
6.19
73.60%
CH:SANN
Santhera Pharmaceuticals Holding
14.12
-0.84
-5.61%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts